p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B

Experimental Eye Research
Nida IqbalStephen X Skapek

Abstract

Arf encodes an important tumor suppressor, p19(Arf), which also plays a critical role to control hyperplasia in the primary vitreous during mouse eye development. In the absence of Arf, mice are born blind and display a phenotype closely mimicking severe forms of the human eye disease, persistent hyperplastic primary vitreous (PHPV). In this report, we characterize p19(Arf) expression in perivascular cells that normally populate the primary vitreous and express the Arf promoter. Using a new ex vivo model, we show that these cells respond to exogenous Tgfβ, despite being isolated at a time when Tgfβ has already turned on the Arf promoter. Treatment of the cells with PDGF-B ligand doubles the population of cells in S-phase and ectopic expression of Arf blunts that effect. We show this effect is mediated through Pdgfrβ as expression of Arf represses expression of Pdgfrβ mRNA and protein to approximately 60%. p53 is not required for Arf-dependent blockade of PDGF-B driven proliferation and repression of Pdgfrβ protein as ectopic expression of Arf is still able to inhibit the 2-fold increase in the S-phase fraction of cells upon treatment with PDGF-B. Finally, induction of mature miR-34a, a microRNA previously identified to be regul...Continue Reading

References

Nov 24, 1998·Developmental Dynamics : an Official Publication of the American Association of Anatomists·C A MitchellH C Drexler
Apr 14, 1999·Cell Death and Differentiation·M B ReichelD M Hunt
Aug 25, 1999·Anatomy and Embryology·M Ito, M Yoshioka
Nov 13, 1999·Nature Cell Biology·J D WeberD Bar-Sagi
Sep 20, 2000·Genes & Development·J D WeberG P Zambetti
Sep 23, 2000·Nature·G D YancopoulosJ Holash
Jan 11, 2002·Developmental Biology·S SaikaW W Kao
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robyn N McKellerStephen X Skapek
Jul 13, 2002·Journal of Cellular Physiology·Sean F HackettPeter A Campochiaro
Mar 7, 2003·Molecular Cell·Masataka SugimotoCharles J Sherr
Dec 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Frederique ZindyCharles J Sherr
Jun 17, 2004·The Journal of Biological Chemistry·Abhishek DattaPradip Raychaudhuri
Sep 29, 2004·Investigative Ophthalmology & Visual Science·Amy C MartinStephen X Skapek
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kenji TagoCharles J Sherr
Jun 21, 2005·The British Journal of Ophthalmology·A HuntF Martin
Jul 23, 2005·The EMBO Journal·Ricardo L A SilvaStephen X Skapek
Jan 26, 2007·Investigative Ophthalmology & Visual Science·J Derek ThorntonStephen X Skapek
May 26, 2009·Development·Natalie E Freeman-AndersonStephen X Skapek
Jul 21, 2010·Experimental Cell Research·Mia NiklassonKarin Forsberg-Nilsson
Sep 10, 2010·The Journal of Biological Chemistry·Yanbin ZhengStephen X Skapek
Jan 10, 2014·Cell Cycle·Nida IqbalStephen X Skapek

❮ Previous
Next ❯

Citations

Jun 28, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jolieke G van OosterwijkCharles J Sherr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.